Cargando…

Costs and cost-effectiveness of HIV counselling and testing modalities in Southern Mozambique

OBJECTIVE: Despite the high HIV associated burden, Mozambique lacks data on HIV counselling and testing (HCT) costs. To help guide national HIV/AIDS programs, we estimated the cost per test for voluntary counselling and testing (VCT) from the patient’s perspective and the costs per person tested and...

Descripción completa

Detalles Bibliográficos
Autores principales: Choo, Jun Hao, Lopez-Varela, Elisa, Fuente-Soro, Laura, Augusto, Orvalho, Sacoor, Charfudin, Nhacolo, Ariel, Wei, Stanley, Naniche, Denise, Thomas, Ranjeeta, Sicuri, Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9447341/
https://www.ncbi.nlm.nih.gov/pubmed/36068574
http://dx.doi.org/10.1186/s12962-022-00378-9
_version_ 1784783837171023872
author Choo, Jun Hao
Lopez-Varela, Elisa
Fuente-Soro, Laura
Augusto, Orvalho
Sacoor, Charfudin
Nhacolo, Ariel
Wei, Stanley
Naniche, Denise
Thomas, Ranjeeta
Sicuri, Elisa
author_facet Choo, Jun Hao
Lopez-Varela, Elisa
Fuente-Soro, Laura
Augusto, Orvalho
Sacoor, Charfudin
Nhacolo, Ariel
Wei, Stanley
Naniche, Denise
Thomas, Ranjeeta
Sicuri, Elisa
author_sort Choo, Jun Hao
collection PubMed
description OBJECTIVE: Despite the high HIV associated burden, Mozambique lacks data on HIV counselling and testing (HCT) costs. To help guide national HIV/AIDS programs, we estimated the cost per test for voluntary counselling and testing (VCT) from the patient’s perspective and the costs per person tested and per HIV-positive individual linked to care to the healthcare provider for VCT, provider-initiated counselling and testing (PICT) and home-based testing (HBT). We also assessed the cost-effectiveness of these strategies for linking patients to care. METHODS: Data from a cohort study conducted in the Manhiça District were used to derive costs and linkage-to-care outcomes of the three HCT strategies. A decision tree was used to model HCT costs according to the likelihood of HCT linking individuals to care and to obtain the incremental cost-effectiveness ratios (ICERs) of PICT and HBT with VCT as the comparator. Sensitivity analyses were performed to assess robustness of base-case findings. FINDINGS: Based on costs and valuations in 2015, average and median VCT costs to the patient per individual tested were US$1.34 and US$1.08, respectively. Costs per individual tested were greatest for HBT (US$11.07), followed by VCT (US$7.79), and PICT (US$7.14). The costs per HIV-positive individual linked to care followed a similar trend. PICT was not cost-effective in comparison with VCT at a willingness-to-accept threshold of US$4.53, but only marginally given a corresponding base-case ICER of US$4.15, while HBT was dominated, with higher costs and lower impact than VCT. Base-case results for the comparison between PICT and VCT presented great uncertainty, whereas findings for HBT were robust. CONCLUSION: PICT and VCT are likely equally cost-effective in Manhiça. We recommend that VCT be offered as the predominant HCT strategy in Mozambique, but expansion of PICT could be considered in limited-resource areas. HBT without facilitated linkage or reduced costs is unlikely to be cost-effective.
format Online
Article
Text
id pubmed-9447341
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94473412022-09-07 Costs and cost-effectiveness of HIV counselling and testing modalities in Southern Mozambique Choo, Jun Hao Lopez-Varela, Elisa Fuente-Soro, Laura Augusto, Orvalho Sacoor, Charfudin Nhacolo, Ariel Wei, Stanley Naniche, Denise Thomas, Ranjeeta Sicuri, Elisa Cost Eff Resour Alloc Research OBJECTIVE: Despite the high HIV associated burden, Mozambique lacks data on HIV counselling and testing (HCT) costs. To help guide national HIV/AIDS programs, we estimated the cost per test for voluntary counselling and testing (VCT) from the patient’s perspective and the costs per person tested and per HIV-positive individual linked to care to the healthcare provider for VCT, provider-initiated counselling and testing (PICT) and home-based testing (HBT). We also assessed the cost-effectiveness of these strategies for linking patients to care. METHODS: Data from a cohort study conducted in the Manhiça District were used to derive costs and linkage-to-care outcomes of the three HCT strategies. A decision tree was used to model HCT costs according to the likelihood of HCT linking individuals to care and to obtain the incremental cost-effectiveness ratios (ICERs) of PICT and HBT with VCT as the comparator. Sensitivity analyses were performed to assess robustness of base-case findings. FINDINGS: Based on costs and valuations in 2015, average and median VCT costs to the patient per individual tested were US$1.34 and US$1.08, respectively. Costs per individual tested were greatest for HBT (US$11.07), followed by VCT (US$7.79), and PICT (US$7.14). The costs per HIV-positive individual linked to care followed a similar trend. PICT was not cost-effective in comparison with VCT at a willingness-to-accept threshold of US$4.53, but only marginally given a corresponding base-case ICER of US$4.15, while HBT was dominated, with higher costs and lower impact than VCT. Base-case results for the comparison between PICT and VCT presented great uncertainty, whereas findings for HBT were robust. CONCLUSION: PICT and VCT are likely equally cost-effective in Manhiça. We recommend that VCT be offered as the predominant HCT strategy in Mozambique, but expansion of PICT could be considered in limited-resource areas. HBT without facilitated linkage or reduced costs is unlikely to be cost-effective. BioMed Central 2022-09-06 /pmc/articles/PMC9447341/ /pubmed/36068574 http://dx.doi.org/10.1186/s12962-022-00378-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Choo, Jun Hao
Lopez-Varela, Elisa
Fuente-Soro, Laura
Augusto, Orvalho
Sacoor, Charfudin
Nhacolo, Ariel
Wei, Stanley
Naniche, Denise
Thomas, Ranjeeta
Sicuri, Elisa
Costs and cost-effectiveness of HIV counselling and testing modalities in Southern Mozambique
title Costs and cost-effectiveness of HIV counselling and testing modalities in Southern Mozambique
title_full Costs and cost-effectiveness of HIV counselling and testing modalities in Southern Mozambique
title_fullStr Costs and cost-effectiveness of HIV counselling and testing modalities in Southern Mozambique
title_full_unstemmed Costs and cost-effectiveness of HIV counselling and testing modalities in Southern Mozambique
title_short Costs and cost-effectiveness of HIV counselling and testing modalities in Southern Mozambique
title_sort costs and cost-effectiveness of hiv counselling and testing modalities in southern mozambique
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9447341/
https://www.ncbi.nlm.nih.gov/pubmed/36068574
http://dx.doi.org/10.1186/s12962-022-00378-9
work_keys_str_mv AT choojunhao costsandcosteffectivenessofhivcounsellingandtestingmodalitiesinsouthernmozambique
AT lopezvarelaelisa costsandcosteffectivenessofhivcounsellingandtestingmodalitiesinsouthernmozambique
AT fuentesorolaura costsandcosteffectivenessofhivcounsellingandtestingmodalitiesinsouthernmozambique
AT augustoorvalho costsandcosteffectivenessofhivcounsellingandtestingmodalitiesinsouthernmozambique
AT sacoorcharfudin costsandcosteffectivenessofhivcounsellingandtestingmodalitiesinsouthernmozambique
AT nhacoloariel costsandcosteffectivenessofhivcounsellingandtestingmodalitiesinsouthernmozambique
AT weistanley costsandcosteffectivenessofhivcounsellingandtestingmodalitiesinsouthernmozambique
AT nanichedenise costsandcosteffectivenessofhivcounsellingandtestingmodalitiesinsouthernmozambique
AT thomasranjeeta costsandcosteffectivenessofhivcounsellingandtestingmodalitiesinsouthernmozambique
AT sicurielisa costsandcosteffectivenessofhivcounsellingandtestingmodalitiesinsouthernmozambique